Lidia Cerquetti

Rome, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Effects of Sorafenib, a Tyrosin Kinase Inhibitor, on Adrenocortical Cancer.

Effects of Sorafenib, a Tyrosin Kinase Inhibitor, on Adrenocortical Cancer.

Journal: Frontiers in endocrinology

Published: February 14, 2021

Antineoplastic Effect of a Combined Mitotane Treatment/Ionizing Radiation in Adrenocortical Carcinoma: A Preclinical Study.

Antineoplastic Effect of a Combined Mitotane Treatment/Ionizing Radiation in Adrenocortical Carcinoma: A Preclinical Study.

Journal: Cancers

Published: October 05, 2019

Treatment responses to antiangiogenetic therapy and chemotherapy in nonsecreting paraganglioma (PGL4) of urinary bladder with SDHB mutation: A case report.

Treatment responses to antiangiogenetic therapy and chemotherapy in nonsecreting paraganglioma (PGL4) of urinary bladder with SDHB mutation: A case report.

Journal: Medicine

Published: July 26, 2018

Effect of mitotane on mouse ovarian follicle development and fertility.

Effect of mitotane on mouse ovarian follicle development and fertility.

Journal: The Journal of endocrinology

Published: April 14, 2017

Pharmacological treatment in adrenal Cushing's syndrome.

Pharmacological treatment in adrenal Cushing's syndrome.

Journal: Recenti progressi in medicina

Published: November 22, 2016

New insights and future perspectives in the therapeutic strategy of adrenocortical carcinoma (Review).

New insights and future perspectives in the therapeutic strategy of adrenocortical carcinoma (Review).

Journal: Oncology reports

Published: August 03, 2016

A multicenter experience on the prevalence of ARMC5 mutations in patients with primary bilateral macronodular adrenal hyperplasia: from genetic characterization to clinical phenotype.

A multicenter experience on the prevalence of ARMC5 mutations in patients with primary bilateral macronodular adrenal hyperplasia: from genetic characterization to clinical phenotype.

Journal: Endocrine

Published: February 11, 2016

GPER agonist G-1 decreases adrenocortical carcinoma (ACC) cell growth in vitro and in vivo.

GPER agonist G-1 decreases adrenocortical carcinoma (ACC) cell growth in vitro and in vivo.

Journal: Oncotarget

Published: January 30, 2015

C-MYC modulation induces responsiveness to paclitaxel in adrenocortical cancer cell lines.

C-MYC modulation induces responsiveness to paclitaxel in adrenocortical cancer cell lines.

Journal: International journal of oncology

Published: November 03, 2014

Human placenta-derived neurospheres are susceptible to transformation after extensive in vitro expansion.

Human placenta-derived neurospheres are susceptible to transformation after extensive in vitro expansion.

Journal: Stem cell research & therapy

Published: May 30, 2013

Targeting estrogen receptor-α reduces adrenocortical cancer (ACC) cell growth in vitro and in vivo: potential therapeutic role of selective estrogen receptor modulators (SERMs) for ACC treatment.

Targeting estrogen receptor-α reduces adrenocortical cancer (ACC) cell growth in vitro and in vivo: potential therapeutic role of selective estrogen receptor modulators (SERMs) for ACC treatment.

Journal: The Journal of clinical endocrinology and metabolism

Published: October 18, 2012

p53 Stabilization induces cell growth inhibition and affects IGF2 pathway in response to radiotherapy in adrenocortical cancer cells.

p53 Stabilization induces cell growth inhibition and affects IGF2 pathway in response to radiotherapy in adrenocortical cancer cells.

Journal: PloS one

Published: April 23, 2012

Showing 1-12 of 13

Last Updated: 09/26/2026